Clinical trials of FineVision (PhysIOL) trifocal intraocular lens
Not Applicable
Completed
- Conditions
- Cataract causing impaired visual function
- Registration Number
- JPRN-UMIN000024869
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of ocular diseases including: age-related macular degeneration of the macula; advanced glaucoma (severe visual field abnormality); keratoconus; ruptured Zinn's zonule and other corneal diseases. Patients with a history of cornea refractive surgery and patients excluded by a responsible doctor for other reasons to be stated.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of FineVision trifocal intraocular lens in restoring visual function in cataract patients?
How does the FineVision trifocal intraocular lens compare to standard-of-care monofocal lenses in terms of visual acuity and patient satisfaction?
Are there specific biomarkers that predict optimal outcomes with trifocal intraocular lenses in patients with cataract-induced visual impairment?
What are the potential adverse events associated with the FineVision trifocal intraocular lens and how are they managed in clinical practice?
What are the current trends in intraocular lens technology and how does the FineVision trifocal lens fit within the therapeutic landscape for cataract treatment?